Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
7.50    -0.40 (-5.06%)
Bid:
7.00
Ask:
8.00
Spread: 1.00 (14.286%)
Market Cap: £474.94m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

Allergy Thera. News

TRADING UPDATES: Braemar investigation to end; Marula reports delay
22 Sep 2023

TRADING UPDATES: Braemar investigation to end; Marula reports delay

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately repor...

Allergy Therapeutics shares plunge on expected loss and revenue drop
10 Aug 2023

Allergy Therapeutics shares plunge on expected loss and revenue drop

(Alliance News) - Allergy Therapeutics PLC on Thursday said it expects to swing to a loss for the full-year as revenue plummets on production disrupti...

Allergy Therapeutics appoints new CFO; interim CFO to leave in August
10 Jul 2023

Allergy Therapeutics appoints new CFO; interim CFO to leave in August

(Alliance News) - Allergy Therapeutics PLC on Monday said it has promoted Group Financial Controller Shaun Furlong to chief financial officer.

Allergy Therapeutics banks on second half-year to boost revenue
19 Jun 2023

Allergy Therapeutics banks on second half-year to boost revenue

(Alliance News) - Allergy Therapeutics PLC on Monday said its loss widened and revenue fell, with costs going up as new research studies progress, but...

Allergy Therapeutics enters GBP41 million facility with ZQ Capital
6 Apr 2023

Allergy Therapeutics enters GBP41 million facility with ZQ Capital

(Alliance News) - Allergy Therapeutics PLC on Thursday said it has entered into a senior secured facility agreement with ZQ Capital Management Ltd, th...

TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy
27 Mar 2023

TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Allergy Therapeutics starts dosing peanut allergy vaccine candidate
27 Mar 2023

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first applicati...

Allergy Therapeutics confident in funding as results remain late
20 Jan 2023

Allergy Therapeutics confident in funding as results remain late

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m...